1. Academic Validation
  2. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

  • Cell. 1996 Nov 15;87(4):619-28. doi: 10.1016/s0092-8674(00)81382-3.
J Zha 1 H Harada E Yang J Jockel S J Korsmeyer
Affiliations

Affiliation

  • 1 Department of Medicine, Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri 63110, USA.
Abstract

Extracellular survival factors alter a cell's susceptibility to Apoptosis, often through posttranslational mechanisms. However, no consistent relationship has been established between such survival signals and the Bcl-2 Family, where the balance of death agonists versus antagonists determines susceptibility. One distant member, BAD, heterodimerizes with BCL-X(L) or Bcl-2, neutralizing their protective effect and promoting cell death. In the presence of survival factor IL-3, cells phosphorylated BAD on two serine residues embedded in 14-3-3 consensus binding sites. Only the nonphosphorylated BAD heterodimerized with BCL-X(L) at membrane sites to promote cell death. Phosphorylated BAD was sequestered in the cytosol bound to 14-3-3. Substitution of serine phosphorylation sites further enhanced BAD's death-promoting activity. The rapid phosphorylation of BAD following IL-3 connects a proximal survival signal with the Bcl-2 Family, modulating this checkpoint for Apoptosis.

Figures